Silibinin alleviates intestinal inflammation via inhibiting JNK signaling in Drosophila

Inflammatory bowel diseases (IBDs) are characterized by chronic relapsing intestinal inflammation that causes digestive system dysfunction. For years, researchers have been working to find more effective and safer therapeutic strategies to treat these diseases. Silibinin (SIL), a flavonoid compound...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, La, Zhou, Juanyu, Yuan, Lu, Ye, Jinbao, Zhao, Xudong, Ren, Gang, Chen, Haiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539474/
https://www.ncbi.nlm.nih.gov/pubmed/37781701
http://dx.doi.org/10.3389/fphar.2023.1246960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539474/
https://www.ncbi.nlm.nih.gov/pubmed/37781701
http://dx.doi.org/10.3389/fphar.2023.1246960

Ejemplares similares